Department of Anesthesiology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.
Department of Anesthesiology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan.
Sci Rep. 2023 Apr 4;13(1):5526. doi: 10.1038/s41598-023-32512-9.
Chronic pain and attention-deficit hyperactivity disorder (ADHD) frequently coexist. However, the common pathology is still unclear. Attenuated noradrenergic endogenous analgesia can produce acute pain chronification, and dysfunction of noradrenergic systems in the nervous system is relevant to ADHD symptoms. Noxious stimuli-induced analgesia (NSIA) is measured to estimate noradrenergic endogenous analgesia in spontaneously hypertensive rats (SHR) as an ADHD model and control. Recovery of pain-related behaviors after paw incision was assessed. Contributions of noradrenergic systems were examined by in vivo microdialysis and immunohistochemistry. The SHR showed attenuated NSIA and needed a more extended period for recovery from acute pain. These results suggest ADHD patients exhibit acute pain chronification due to pre-existing attenuated noradrenergic endogenous analgesia. Immunohistochemistry suggests abnormal noradrenaline turnover and downregulation of the target receptor (alpha2a adrenoceptor). Standard ADHD treatment with atomoxetine restored NSIA and shortened the duration of hypersensitivity after the surgery in the SHR. NSIA protocol activated the locus coeruleus, the origin of spinal noradrenaline, of both strains, but only the control exhibited an increase in spinal noradrenaline. This result suggests dysfunction in the noradrenaline-releasing process and can be recognized as a novel mechanism of attenuation of noradrenergic endogenous analgesia.
慢性疼痛和注意缺陷多动障碍(ADHD)经常同时存在。然而,其共同的发病机制仍不清楚。去甲肾上腺素能内源性镇痛作用减弱可导致急性疼痛慢性化,而神经系统去甲肾上腺素能系统功能障碍与 ADHD 症状相关。通过测量伤害性刺激诱导的镇痛(NSIA)来评估自发性高血压大鼠(SHR)作为 ADHD 模型和对照组的内源性去甲肾上腺素能镇痛。评估了爪切开后疼痛相关行为的恢复情况。通过体内微透析和免疫组织化学检查了去甲肾上腺素能系统的作用。SHR 表现出 NSIA 减弱,需要更长的时间从急性疼痛中恢复。这些结果表明 ADHD 患者由于预先存在的去甲肾上腺素能内源性镇痛作用减弱而表现出急性疼痛慢性化。免疫组织化学表明去甲肾上腺素代谢异常和靶受体(α2a 肾上腺素能受体)下调。标准 ADHD 治疗药物托莫西汀恢复了 SHR 的 NSIA,并缩短了手术后的过敏持续时间。NSIA 方案激活了两种品系的蓝斑,即脊髓去甲肾上腺素的起源,但只有对照组表现出脊髓去甲肾上腺素的增加。这一结果提示去甲肾上腺素释放过程的功能障碍,可被认为是去甲肾上腺素能内源性镇痛作用减弱的一种新机制。